Lung diseases are one of the most common medical conditions in the world affecting more than 10 million people all over the world. They can arise due to problems associated with any part of the respiratory system, leading to Interstitial Lung Diseases (ILD). Chronic Obstructive Pulmonary Disease (COPD) also known as chronic obstructive airway disease is a type of lung disease characterized by the progressively poor passage of airflow associated with difficulty in breathing, excessive cough and sputum are the other common symptoms of COPD.

Emphysema, a common type of COPD, is a progressive disorder with no treatment available in conventional medicine. However, Stem Cell Therapy can help to slow down the progression of the disease, treat the obstructed airways to relieve associated hypoxia and improve the overall quality of life for Emphysema patients. Stem cell therapy for ILD and COPD, besides other lung disease treatment, help in protecting the lung tissue by suppressing inflammation caused by pollutants, accelerate regeneration of airway tubes and air sacs. They can even efficiently trigger production of growth factors which further facilitates regeneration.

Stem Cell Therapy For Lung Diseases: Advancells Protocol

We are exploiting the most potent stem cells, for lung disease stem cell treatment, from patients’ own Bone Marrow or Adipose tissue or maybe both depending upon the assessment. Our top priority is to provide a very comprehensive and individualized lung disease stem cell treatment pattern which is best suited for the patients. Since the body’s own cells are used the technique is very safe with no side effects, non-invasive and effective.

With extensive research these challenges are now comprehensible to therapeutic ventures resulting in stem cell treatment for lung diseases using autologous treatment/allogenic transplant for adipose-derived mesenchymal stromal cells treatment and bone marrow stromal cells treatment. This new insight on the treatment of lung diseases has helped in identifying the potential to overcome lung diseases with stem cells, primarily using autologous stem cell transplant in form of hematopoietic stem cell transplant or mesenchymal stromal cells treatment.